Cover Image
市場調查報告書

下垂體ACTH分泌過剩(庫欣氏症):全球臨床實驗檢討

Pituitary ACTH Hypersecretion (Cushing Disease) Global Clinical Trials Review, H1, 2016

出版商 GlobalData 商品編碼 305093
出版日期 內容資訊 英文 71 Pages
訂單完成後即時交付
價格
Back to Top
下垂體ACTH分泌過剩(庫欣氏症):全球臨床實驗檢討 Pituitary ACTH Hypersecretion (Cushing Disease) Global Clinical Trials Review, H1, 2016
出版日期: 2016年06月30日 內容資訊: 英文 71 Pages
簡介

庫欣氏症是指下垂體過度釋放腎上腺皮質刺激荷爾蒙(ACTH)的狀態。下垂體ACTH分泌過剩,是庫欣氏症候群的一種。

本報告提供下垂體ACTH分泌過剩(庫欣氏症)的治療藥相關臨床實驗調查分析,提供臨床實驗數及被實驗人數,各階段及各方面狀況,有潛力的企業,開發中的治療藥資訊,臨床實驗簡介等相關的系統性資訊。

目錄

簡介

各地區的臨床實驗

  • 各國臨床實驗趨勢
    • 亞太地區的主要國家
    • 歐洲的主要國家
    • 北美的主要國家
    • 中東·非洲的主要國家
    • 中南美的主要國家

G7各國的臨床實驗:代謝障礙臨床實驗中,下垂體ACTH分泌過剩(庫欣氏症)的比例

G7各國的臨床實驗:Phase別

G7各國的臨床實驗:各階段

E7各國的臨床實驗:代謝障礙臨床實驗中,下垂體ACTH分泌過剩(庫欣氏症)的比例

E7各國的臨床實驗:Phase別

E7各國的臨床實驗:各階段

各方面的臨床實驗

各階段臨床實驗

未完成的臨床實驗

一定期間所採用的實驗對象

贊助商各類型臨床實驗

有潛力的贊助商

  • 參與下垂體ACTH分泌過剩(庫欣氏症)治療藥臨床實驗的主要企業

有前途藥物

臨床實驗簡介

  • 主要企業臨床實驗概要
    • Novartis AG
    • Corcept Therapeutics Incorporated
    • Isis Pharmaceuticals, Inc.
    • Laboratoires Pierre Fabre SA
    • Cortendo Invest AB
  • 主要大學·研究機關·醫院臨床實驗概要
    • Eunice Kennedy Shriver National Institute of Child Health and Human Development
    • National Center for Research Resources
    • University of Wurzburg
    • UCLA's Jonsson Comprehensive Cancer Center
    • Erasmus MC
    • Massachusetts General Hospital
    • Assistance Publique - Hopitaux de Paris
    • 廣島大學醫院
    • Universita di Padova
    • Samsung Medical Center

主要的臨床簡介

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC3514CTIDB

GlobalData's clinical trial report, "Pituitary ACTH Hypersecretion (Cushing Disease) Global Clinical Trials Review, H1, 2016" provides an overview of Pituitary ACTH Hypersecretion (Cushing Disease) clinical trials scenario. This report provides top line data relating to the clinical trials on Pituitary ACTH Hypersecretion (Cushing Disease). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Pituitary ACTH Hypersecretion (Cushing Disease) to Metabolic Disorders Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Pituitary ACTH Hypersecretion (Cushing Disease) to Metabolic Disorders Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Pituitary ACTH Hypersecretion (Cushing Disease) Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profile Snapshots
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Pituitary ACTH Hypersecretion (Cushing Disease) Therapeutics, Global, Clinical Trials by Region, 2016*
  • Pituitary ACTH Hypersecretion (Cushing Disease) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016*
  • Pituitary ACTH Hypersecretion (Cushing Disease) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016*
  • Pituitary ACTH Hypersecretion (Cushing Disease) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016*
  • Pituitary ACTH Hypersecretion (Cushing Disease) Therapeutics Clinical Trials, Europe, Top Five Countries, 2016*
  • Pituitary ACTH Hypersecretion (Cushing Disease) Therapeutics Clinical Trials, North America, Top Countries, 2016*
  • Pituitary ACTH Hypersecretion (Cushing Disease) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016*
  • Pituitary ACTH Hypersecretion (Cushing Disease) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2016*
  • Proportion of Pituitary ACTH Hypersecretion (Cushing Disease) to Metabolic Disorders Clinical Trials, G7 Countries (%), 2016*
  • Pituitary ACTH Hypersecretion (Cushing Disease) Therapeutics, G7 Countries, Clinical Trials by Phase, 2016*
  • Pituitary ACTH Hypersecretion (Cushing Disease) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016*
  • Proportion of Pituitary ACTH Hypersecretion (Cushing Disease) to Metabolic Disorders Clinical Trials, E7 Countries (%), 2016*
  • Pituitary ACTH Hypersecretion (Cushing Disease) Therapeutics, E7 Countries, Clinical Trials by Phase, 2016*
  • Pituitary ACTH Hypersecretion (Cushing Disease) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016*
  • Pituitary ACTH Hypersecretion (Cushing Disease) Therapeutics, Global, Clinical Trials by Phase, 2016*
  • Pituitary ACTH Hypersecretion (Cushing Disease) Therapeutics, Global, Clinical Trials In Progress by Phase 2016*
  • Pituitary ACTH Hypersecretion (Cushing Disease) Therapeutics, Global, Clinical Trials by Trial Status, 2016*
  • Pituitary ACTH Hypersecretion (Cushing Disease) Therapeutics Clinical Trials, Global, by End Point Status, 2016*
  • Pituitary ACTH Hypersecretion (Cushing Disease) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015
  • Pituitary ACTH Hypersecretion (Cushing Disease) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016*
  • Pituitary ACTH Hypersecretion (Cushing Disease) Therapeutics Clinical Trials, Global, Key Sponsors, 2016*
  • Pituitary ACTH Hypersecretion (Cushing Disease) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016*
  • Pituitary ACTH Hypersecretion (Cushing Disease) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016*

List of Figures

  • Pituitary ACTH Hypersecretion (Cushing Disease) Therapeutics, Global, Clinical Trials by Region (%), 2016*
  • Pituitary ACTH Hypersecretion (Cushing Disease) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016*
  • Pituitary ACTH Hypersecretion (Cushing Disease) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016*
  • Pituitary ACTH Hypersecretion (Cushing Disease) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016*
  • Pituitary ACTH Hypersecretion (Cushing Disease) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016*
  • Pituitary ACTH Hypersecretion (Cushing Disease) Therapeutics Clinical Trials, North America, Top Countries (%), 2016*
  • Pituitary ACTH Hypersecretion (Cushing Disease) Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2016*
  • Pituitary ACTH Hypersecretion (Cushing Disease) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2016*
  • Proportion of Pituitary ACTH Hypersecretion (Cushing Disease) to Metabolic Disorders Clinical Trials, G7 Countries (%), 2016*
  • Pituitary ACTH Hypersecretion (Cushing Disease) Therapeutics, G7 Countries, Clinical Trials by Phase, 2016*
  • Pituitary ACTH Hypersecretion (Cushing Disease) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016*
  • Proportion of Pituitary ACTH Hypersecretion (Cushing Disease) to Metabolic Disorders Clinical Trials, E7 Countries (%), 2016*
  • Pituitary ACTH Hypersecretion (Cushing Disease) Therapeutics, E7 Countries, Clinical Trials by Phase, 2016*
  • Pituitary ACTH Hypersecretion (Cushing Disease) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016*
  • Pituitary ACTH Hypersecretion (Cushing Disease) Therapeutics, Global, Clinical Trials by Phase (%), 2016*
  • Pituitary ACTH Hypersecretion (Cushing Disease) Therapeutics, Global, Clinical Trials In Progress by Phase, 2016*
  • Pituitary ACTH Hypersecretion (Cushing Disease) Therapeutics, Global, Clinical Trials by Trial Status, 2016*
  • Pituitary ACTH Hypersecretion (Cushing Disease) Therapeutics Clinical Trials, Global, by End Point Status, 2016*
  • Pituitary ACTH Hypersecretion (Cushing Disease) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015
  • Pituitary ACTH Hypersecretion (Cushing Disease) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016*
  • Pituitary ACTH Hypersecretion (Cushing Disease) Therapeutics Clinical Trials, Global, Key Sponsors, 2016*
  • Pituitary ACTH Hypersecretion (Cushing Disease) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016*
  • Pituitary ACTH Hypersecretion (Cushing Disease) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016*
  • GlobalData Methodology
Back to Top